Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Int J Radiat Oncol Biol Phys
.
2020 Dec 1;108(5):1398.
doi: 10.1016/j.ijrobp.2020.09.020.
Epub 2020 Nov 18.
Authors
K A Higgins
1
,
W J Curran Jr
1
,
S V Liu
2
,
W Yu
3
,
M Brockman
3
,
A Johnson
3
,
I Bara
3
,
J D Bradley
1
Affiliations
1
Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
2
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
3
Genentech, Inc., South San Francisco, CA.
PMID:
33427656
DOI:
10.1016/j.ijrobp.2020.09.020
No abstract available